Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Canadian Journal of Physiology and Pharmacology
|
December 22, 2018
Klotho protein inhibits H<sub>2</sub>O<sub>2</sub>-induced oxidative injury in endothelial cells via regulation of PI3K/AKT/Nrf2/HO-1 pathways
Wei Cui, Bin Leng, GaoPin Wang
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
November 25, 2018
Suppression of Apoptosis in Human Umbilical Vein Endothelial Cells (HUVECs) by Klotho Protein is Associated with Reduced Endoplasmic Reticulum Oxidative Stress and Activation of the PI3K/AKT Pathway
Wei Cui, Bin Leng, Wei Liu, et al.
Folia Histochemica Et Cytobiologica
|
December 30, 2022
Overexpressing six-transmembrane protein of prostate 2 (STAMP2) alleviates sepsis-induced acute lung injury probably by hindering M1 macrophage polarization via the NF-κB pathway
Lili Ji, Xiaojing Shi, Gaopin Wang, et al.
BMC Cardiovascular Disorders
|
March 17, 2017
Electrocardiogram: his bundle potentials can be recorded noninvasively beat by beat on surface electrocardiogram
Gaopin Wang, Renguang Liu, Qinghua Chang, et al.
Pacing and Clinical Electrophysiology : PACE
|
January 20, 2017
Effects of Antegrade Accessory Pathway Conduction on QRS Terminal Vector in Patients with Preexcitation Syndrome
Renguang Liu, Q I Chen, Yang Chen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
June 12, 2024
Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia
Wang Zhao, Zhifeng Cheng, Xianyou Ji, et al.
European Journal of Preventive Cardiology
|
August 31, 2023
Refining prediction of stroke in sinus node dysfunction patients without atrial fibrillation using a P-combined score: a multi-centre study
Haoyu Dong, Yan Zhang, Dongxu Sun, et al.
Atherosclerosis
|
June 21, 2025
Efficacy and safety of ongericimab in Chinese statin-intolerant patients with primary hypercholesterolemia or mixed dyslipidemia: a randomized, placebo-controlled phase 3 trial
Chunli Shao, Shu Zhang, Zhifeng Cheng, et al.
Journal of the American Heart Association
|
May 31, 2024
Efficacy and Safety of Ongericimab in Chinese Patients With Primary Hypercholesterolemia and Mixed Dyslipidemia
Xiaozeng Wang, Miaohan Qiu, Zhifeng Cheng, et al.
Atherosclerosis
|
February 25, 2025
Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial
Jie Lin, Yuan Ji, Gaopin Wang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Canadian Journal of Physiology and Pharmacology
|
December 22, 2018
Klotho protein inhibits H<sub>2</sub>O<sub>2</sub>-induced oxidative injury in endothelial cells via regulation of PI3K/AKT/Nrf2/HO-1 pathways
Wei Cui, Bin Leng, GaoPin Wang
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
November 25, 2018
Suppression of Apoptosis in Human Umbilical Vein Endothelial Cells (HUVECs) by Klotho Protein is Associated with Reduced Endoplasmic Reticulum Oxidative Stress and Activation of the PI3K/AKT Pathway
Wei Cui, Bin Leng, Wei Liu, et al.
Folia Histochemica Et Cytobiologica
|
December 30, 2022
Overexpressing six-transmembrane protein of prostate 2 (STAMP2) alleviates sepsis-induced acute lung injury probably by hindering M1 macrophage polarization via the NF-κB pathway
Lili Ji, Xiaojing Shi, Gaopin Wang, et al.
BMC Cardiovascular Disorders
|
March 17, 2017
Electrocardiogram: his bundle potentials can be recorded noninvasively beat by beat on surface electrocardiogram
Gaopin Wang, Renguang Liu, Qinghua Chang, et al.
Pacing and Clinical Electrophysiology : PACE
|
January 20, 2017
Effects of Antegrade Accessory Pathway Conduction on QRS Terminal Vector in Patients with Preexcitation Syndrome
Renguang Liu, Q I Chen, Yang Chen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
June 12, 2024
Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia
Wang Zhao, Zhifeng Cheng, Xianyou Ji, et al.
European Journal of Preventive Cardiology
|
August 31, 2023
Refining prediction of stroke in sinus node dysfunction patients without atrial fibrillation using a P-combined score: a multi-centre study
Haoyu Dong, Yan Zhang, Dongxu Sun, et al.
Atherosclerosis
|
June 21, 2025
Efficacy and safety of ongericimab in Chinese statin-intolerant patients with primary hypercholesterolemia or mixed dyslipidemia: a randomized, placebo-controlled phase 3 trial
Chunli Shao, Shu Zhang, Zhifeng Cheng, et al.
Journal of the American Heart Association
|
May 31, 2024
Efficacy and Safety of Ongericimab in Chinese Patients With Primary Hypercholesterolemia and Mixed Dyslipidemia
Xiaozeng Wang, Miaohan Qiu, Zhifeng Cheng, et al.
Atherosclerosis
|
February 25, 2025
Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial
Jie Lin, Yuan Ji, Gaopin Wang, et al.
Page
of 1